IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

ESANCO PHARMACEUTICAL LLP

LLPIN : AAD-7479|ROC: RoC-ChhattisgarhStrike Off
Last Updated On : 17-02-2026
LLPINAAD-7479
LLP NameESANCO PHARMACEUTICAL LLP
Number of Partners2
Number of Designated Partners2
ROC CodeRoC-Chhattisgarh
Date of Incorporation10-04-2015
Registered AddressBehind V.P Steel Traders Near Maitri Nagar, Mahadev Ghat Road,Maitri Nagar NA Raipur Raipur Chattisgarh India 492001
Email IDsukhraj.vision@gmail.com
Total Obligation of Contribution1,00,000
Main division of business activity to be carried out in India33
Description of main divisionManufacturing (Machinery & Equipments)
LLP StatusStrike Off

Directors / Signatory Details

DIN / PANNameBegin Date
07058360SUKH RAJ SINGH10-04-2015
07064243SUKHJEET SINGH10-04-2015
ESANCO PHARMACEUTICAL LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Chhattisgarh, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 10-04-2015 and last updated on 17-02-2026. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Strike Off” as per MCA records.
From a financial standpoint, ESANCO PHARMACEUTICAL LLP has a total contribution of INR 1,00,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is Behind V.P Steel Traders Near Maitri Nagar, Mahadev Ghat Road,Maitri Nagar NA Raipur Raipur Chattisgarh India 492001. Correspondence or inquiries may be sent to the official email address, sukhraj.vision@gmail.com.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.